-
1
المؤلفون: Ilya G. Glezerman, Jennifer N. Choi, Pamela K. Ginex, Dipti Gupta, Bernardo Leon Rapoport, Tim Cooksley, Douglas B. Johnson, Monica Girotra, Michael Dougan, Vickie R. Shannon, Ronald Anderson, Ada G. Blidner, Maria E. Suarez-Almazor
المصدر: Supportive Care in Cancer. 28:6111-6117
مصطلحات موضوعية: Drug-Related Side Effects and Adverse Reactions, Opportunistic infection, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Context (language use), Ipilimumab, Medical Oncology, Bioinformatics, B7-H1 Antigen, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, Cancer immunotherapy, Neoplasms, Humans, Immunologic Factors, Medicine, CTLA-4 Antigen, 030212 general & internal medicine, Immune Checkpoint Inhibitors, business.industry, Antibodies, Monoclonal, Immunotherapy, medicine.disease, Oncology, 030220 oncology & carcinogenesis, Monoclonal, Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d4394dd591dac51ae0d1be00b8116bTest
https://doi.org/10.1007/s00520-020-05705-5Test -
2
المؤلفون: Michael Dougan, Jennifer N. Choi, Ronald Anderson, Maria E. Suarez-Almazor, Douglas B. Johnson, Tim Cooksley, Ada G. Blidner, Vickie R. Shannon, Ilya G. Glezerman, Bernardo Leon Rapoport, Monica Girotra, Pamela K. Ginex, Dipti Gupta
المصدر: Support Care Cancer
مصطلحات موضوعية: medicine.medical_specialty, Combination therapy, Gastrointestinal Diseases, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Perforation (oil well), History, 21st Century, Severity of Illness Index, Gastroenterology, Article, Vedolizumab, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Internal medicine, medicine, Humans, Immunologic Factors, CTLA-4 Antigen, 030212 general & internal medicine, Palliative Medicine, Adverse effect, Immune Checkpoint Inhibitors, Societies, Medical, Hepatitis, Enterocolitis, business.industry, Palliative Care, International Agencies, Immunotherapy, medicine.disease, Infliximab, Oncology, 030220 oncology & carcinogenesis, Chemical and Drug Induced Liver Injury, medicine.symptom, business, human activities, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9850a49fbe97618d9d0e96e32444070cTest
https://doi.org/10.1007/s00520-020-05707-3Test